Drupal.behaviors.print = function(context) {window.print();window.close();}>
NextPharma to Manufacture Epigenomics' Colon Cancer Test
October 06, 2010
NextPharma to Manufacture Epigenomics' Colon Cancer Test
NextPharma will manufacture Epigenomics' Epi proColon test kit in Europe and other markets.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Epigenomics Initiates PMA Submission for Colorectal Cancer Test
January 4, 2012 / GenomeWeb Daily News
NextPharma Deal Next Step Toward US Distribution of Epigenomics' Colon Cancer Dx
October 7, 2010 / PCR Insider
Dx Focus: Diagnovus Engauge-Cancer-DLBCL; Epigenomics Epi ProColon
February 21, 2013 / PCR Insider
Epigenomics Plans 2012 Submission to FDA for Colon Cancer Test
December 9, 2011 / GenomeWeb Daily News
Epigenomics' Q3 Revenues Fall 29 Percent; PMA Submission Targeted for Epi proColon 2.0
November 9, 2011 / GenomeWeb Daily News